CVS Health Corporation with ticker code (CVS) have now 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $104.00 and $74.00 with the average target price sitting at $87.09. Now with the previous closing price of $76.26 this would indicate that there is a potential upside of 14.2%. It’s also worth noting that there is a 50 day moving average of $70.29 and the 200 moving average now moves to $71.21. The total market capitalization for the company now stands at 100.13B. The current share price for the company is: $77.81 USD
The potential market cap would be $114,354,084,315 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 11.92, revenue per share of $268.63 and a 3.64% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
